Literature DB >> 1901067

Interpretive criteria and quality control guidelines for Neisseria gonorrhoeae susceptibility test standardization for cefotetan.

R N Jones1, E H Gerlach, F P Koontz, P R Murray, M A Pfaller, J A Washington, M E Erwin, C C Knapp.   

Abstract

Cefotetan was tested in a multilaboratory study to standardize susceptibility testing criteria and quality control guidelines for Neisseria gonorrhoeae. Cefotetan was most active against penicillinase-producing and penicillin-susceptible strains (MIC for 50% of strains tested, 0.5 micrograms/ml) and was least active against the chromosomally resistant isolates (MIC for 50% of strains tested, 2 micrograms/ml). The recommended 30-micrograms disk cefotetan interpretive criteria were as follows: susceptible at greater than or equal to 26 mm (less than or equal to 2 micrograms/ml), intermediate at 20 to 25 mm (4 micrograms/ml), and resistant at less than or equal to 19 mm (greater than or equal to 8 micrograms/ml). Quality control guidelines for agar dilution and disk diffusion tests were established by using numerous GC agar lots, three cefotetan 30-micrograms disk lots, two quality control organisms, and a volume of tests consistent with National Committee for Clinical Laboratory Standards M23-T guidelines.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1901067      PMCID: PMC269768          DOI: 10.1128/jcm.29.2.363-366.1991

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN: 0095-1137            Impact factor:   5.948


  11 in total

1.  Susceptibility to cephalosporins of penicillin-susceptible and penicillin-resistant strains of Neisseria gonorrhoeae from Philadelphia.

Authors:  T Fekete; D A Serfass; S C Lafredo; K R Cundy
Journal:  Antimicrob Agents Chemother       Date:  1989-02       Impact factor: 5.191

2.  Single dose cefoxitin in treating uncomplicated gonorrhoea caused by penicillinase producing Neisseria gonorrhoeae (PPNG) and non-PPNG strains.

Authors:  K B Lim; T Thirumoorthy; C T Lee; S N Tham; E H Sng; T Tan
Journal:  Genitourin Med       Date:  1986-08

3.  Comparative pharmacokinetics of cefotetan and cefoxitin in patients undergoing hysterectomies and colorectal operations.

Authors:  R Quintiliani; C H Nightingale; R C Stevens; W R Outman; P J Deckers; M G Martens
Journal:  Am J Surg       Date:  1988-05-31       Impact factor: 2.565

Review 4.  Tetracycline-resistant Neisseria gonorrhoeae.

Authors:  J Heritage; P M Hawkey
Journal:  J Antimicrob Chemother       Date:  1988-11       Impact factor: 5.790

5.  Standardization of disk diffusion and agar dilution susceptibility tests for Neisseria gonorrhoeae: interpretive criteria and quality control guidelines for ceftriaxone, penicillin, spectinomycin, and tetracycline.

Authors:  R N Jones; T L Gavan; C Thornsberry; P C Fuchs; E H Gerlach; J S Knapp; P Murray; J A Washington
Journal:  J Clin Microbiol       Date:  1989-12       Impact factor: 5.948

6.  Evaluation of cefotetan in uncomplicated gonorrhea.

Authors:  H C Korting; D Abeck; U Neubert
Journal:  Dermatologica       Date:  1986

Review 7.  Cefotetan: a review of the microbiologic properties and antimicrobial spectrum.

Authors:  R N Jones
Journal:  Am J Surg       Date:  1988-05-31       Impact factor: 2.565

8.  Spectinomycin-resistant Neisseria gonorrhoeae.

Authors:  C Thornsberry; H Jaffee; S T Brown; T Edwards; J W Biddle; S E Thompson
Journal:  JAMA       Date:  1977-05-30       Impact factor: 56.272

9.  One gram of cefoxitin cures uncomplicated gonococcal urethritis caused by penicillinase-producing Neisseria gonorrhoeae (PPNG).

Authors:  P L Sanchez; F S Wignall; T R Zajdowicz; S Kerbs; S W Berg; W O Harrison
Journal:  Sex Transm Dis       Date:  1983 Jul-Sep       Impact factor: 2.830

10.  Comparison of ceftriaxone with cefoxitin in the treatment of penicillin-resistant gonococcal urethritis.

Authors:  T R Zajdowicz; P L Sanches; S W Berg; S B Kerbs; R L Newquist; W O Harrison
Journal:  Br J Vener Dis       Date:  1983-06
View more
  3 in total

1.  In vitro antibiotic susceptibilities of Neisseria gonorrhoeae isolates in the Philippines.

Authors:  T E Clendennen; C S Hames; E S Kees; F C Price; W J Rueppel; A B Andrada; G E Espinosa; G Kabrerra; F S Wignall
Journal:  Antimicrob Agents Chemother       Date:  1992-02       Impact factor: 5.191

Review 2.  Antimicrobial susceptibility testing of Neisseria gonorrhoeae and implications for epidemiology and therapy.

Authors:  T Fekete
Journal:  Clin Microbiol Rev       Date:  1993-01       Impact factor: 26.132

3.  Antibiotic susceptibility survey of Neisseria gonorrhoeae in Thailand.

Authors:  T E Clendennen; P Echeverria; S Saengeur; E S Kees; J W Boslego; F S Wignall
Journal:  Antimicrob Agents Chemother       Date:  1992-08       Impact factor: 5.191

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.